In case patients have a dual therapy with either a SGLT-2 inhibitor or a TZD and are not at goal, a further treatment escalation to a triple therapy with a DPP-4 inhibitor can be implemented (7072)
Taurines ability to act as a modulator for both dopamine and histamine make it a vital player in this formulation
A key difference between these peptides is that while they both appear to increase the secretion and production of HGH in vitro and in vivo, only tesamorelin has undergone human clinical trials and has been approved by the FDA
Helps give the skin a natural glow and radiance
Pagnotta S, Tramutola A, Barone E, Di Domenico F, Pittal V, Salerno L, Folgiero V, Caforio M, Locatelli F, Petrini S, Butterfield DA, Perluigi M